IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
Mechanisms for the transport and accumulation of albumin-bound... | Download Scientific Diagram
12x Chemo, eisgekühlt bitte! Neuer Wirkstoff Paclitaxel
Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
Chemo Ende, neue Haare und ein Schockmoment!
Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study | British Journal of Cancer
Paclitaxel (Taxol) | NEJM
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial | Nature Communications
12x Chemo, eisgekühlt bitte! Neuer Wirkstoff Paclitaxel
A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice | Translational Psychiatry
Cancers | Free Full-Text | Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer
Paclitaxel with EC Adjuvant or Neoadjuvant Protocol
IJMS | Free Full-Text | Paclitaxel Induces Apoptosis in Breast Cancer Cells through Different Calcium—Regulating Mechanisms Depending on External Calcium Conditions
12x Chemo, eisgekühlt bitte! Neuer Wirkstoff Paclitaxel
Paclitaxel | Antitumor Agent | MedChemExpress
Approved for use in:
Feasibility of AC/EC Followed by Weekly Paclitaxel in Node-positive Breast Cancer in Japan | Anticancer Research
JAMA Network Open on Twitter: "RCT: Epirubicin + paclitaxel was non-inferior to the standard epirubicin + cyclophosphamide followed by paclitaxel in patients with operable HRBB2 negative and lymph nodes-positive breast cancer. https://t.co/Z672x44dQL
